Pavblu™ (aflibercept-ayyh)
for Macular Degeneration

Pavblu (aflibercept-ayyh) is a biosimilar to Eylea used to treat wet age-related macular degeneration (AMD), macular edema from retinal vein occlusion (RVO), diabetic macular edema (DME), and diabetic retinopathy (DR). It is a VEGF inhibitor that binds to VEGF-A to block abnormal blood vessel growth under the retina. Pavblu helps reduce swelling, stop fluid leakage, slow vision loss, and may improve vision in some patients.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Macular Degeneration